ELAVL3

ELAV-like protein 3 · Q14576 · ELAVL3 on Sugi Atlas →

966 patent compounds predicted against ELAVL3, 885 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
Quercetin (SCHEMBL11149166)	0.90	3/20
Quercetin (SCHEMBL5126185)	0.87	3/20
Quercetin (SCHEMBL7186872)	0.87	3/20
Quercetin (SCHEMBL14342895)	0.87	3/20
Quercetin (SCHEMBL7180221)	0.81	3/20
Quercetin (SCHEMBL14786206)	0.81	3/20
Quercetin (SCHEMBL11298145)	0.79	3/20
Quercetin (SCHEMBL20483106)	0.79	3/20
SCHEMBL13856525	0.78	3/20
SCHEMBL11230710	0.77	3/20
Laricytrin (SCHEMBL19213534)	0.77	3/20
SCHEMBL9909444	0.75	3/20
Mearnsetin (SCHEMBL3690508)	0.74	3/20
Quercetin (SCHEMBL4468031)	0.74	3/20
Quercetin (SCHEMBL4473370)	0.74	3/20
SCHEMBL12305080	0.73	3/20
Quercetin (SCHEMBL117829)	0.72	3/20
Quercetin (SCHEMBL3678259)	0.72	3/20
Quercetagetin (SCHEMBL554527)	0.72	3/20
SCHEMBL17451521	0.71	3/20

Clinical trials — most relevant to ELAVL3 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes	PHASE4	UNKNOWN
Influence of Genetics in Pain Sensitivity	PHASE2	COMPLETED
miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome	PHASE2	COMPLETED
Safety Study of a Gene Transfer Vector (Rh.10) for Children With Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)	PHASE1	COMPLETED
The Possible Neuroprotective Effect of Ocrelizumab Via VEGF Protein Expression in Relapsing Multiple Sclerosis Patients	nan	UNKNOWN
Na+ Channel mRNA Regulation in Heart Failure	nan	COMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population	nan	COMPLETED
Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank	nan	COMPLETED
Exploring the Genetics of Neuropathic Pain	nan	RECRUITING
The Influence of Genetic Variations in ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation in Humans	nan	UNKNOWN
Novel Biophotonics Methodology for Colon Cancer Screening	nan	COMPLETED
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants.	nan	UNKNOWN
miR-142-3p as Potential Biomarker of Synaptopathy in MS	nan	UNKNOWN
iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy	nan	COMPLETED
Prognostic Value of Protein IMP3 Expression in Cervical Cancer	nan	COMPLETED
Identification of New FTLD Genes	nan	UNKNOWN
Generating Intervals of Reference FFor Early Life Brain Biomarkers.	nan	RECRUITING
Impact of Elastin Mediated Vascular Stiffness on End Organs	nan	COMPLETED
DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma	nan	COMPLETED
Amyotrophic Lateral Sclerosis (ALS) Families Project	nan	RECRUITING
Longitudinal Study of Neurogenetic Disorders	nan	RECRUITING
Proteomic and Histological Analysis of Ligamentum Flavum in Lumbar Stenosis	nan	RECRUITING
Lung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar Lavage	nan	UNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic	nan	COMPLETED
Pleiotropy and Mechanism of Peripheral Nerve Related Genes in the Progression of Amyotrophic Lateral Sclerosis	nan	UNKNOWN
Identification of Novel Bio-markers for Environmental Enteropathy in Children Using an Evidence Based Approach	nan	COMPLETED
Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis	nan	COMPLETED
Study of Specimens From Young Patients With Neuroblastoma	nan	COMPLETED
Epi-Genetic Modulators of Fear Extinction in Alcohol Dependence	nan	COMPLETED
Evaluating the Relationship of Morphine Consumption and Pain-related Molecules in Hepatic Surgical Patients	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a ELAVL3 binder may also engage these)

Protein	Name	Similarity
Q60900	—	1.000	Q60900 →
Q28FX0	—	0.999	Q28FX0 →
Q28GD4	—	0.995	Q28GD4 →
Q60899	—	0.995	Q60899 →
Q8CH84	—	0.995	Q8CH84 →
Q91584	—	0.994	Q91584 →
Q5R9Z6	—	0.994	Q5R9Z6 →
P26378	—	0.993	P26378 →
Q91903	—	0.992	Q91903 →
A4QNI8	—	0.992	A4QNI8 →
O09032	—	0.991	O09032 →
Q61701	—	0.991	Q61701 →
Q12926	—	0.991	Q12926 →
Q7SZT7	—	0.990	Q7SZT7 →
A0A0R4IEW8	—	0.986	A0A0R4IEW8 →
Q6GLB5	—	0.984	Q6GLB5 →
Q1JQ73	—	0.984	Q1JQ73 →
Q5U259	—	0.983	Q5U259 →
B5DF91	—	0.981	B5DF91 →
ELAVL1	ELAV-like protein 1	0.979	landscape →
Q9M427	—	0.977	Q9M427 →
P70372	—	0.976	P70372 →
Q9IBD1	—	0.975	Q9IBD1 →
Q91579	—	0.973	Q91579 →
Q9LQI9	—	0.973	Q9LQI9 →
Q8WN55	—	0.972	Q8WN55 →
Q7ZWM3	—	0.971	Q7ZWM3 →
Q08E07	—	0.971	Q08E07 →
Q7TN33	—	0.971	Q7TN33 →
PTBP3	Polypyrimidine tract-binding protein 3	0.971	landscape →